Sanofi SNY
NASDAQ SNY
$48.39 +0.02 (+0.04%)
At close: Nov 16, 2026 · 4:00 PM EST

Sanofi (SNY) Return on Equity [ROE] (2018)

Updated

Sanofi's Return on Equity [ROE] was 7.46% in FY2024, up 0.19 percentage points from 7.27% in FY2023.

Analysis

Sanofi (SNY) Return on Equity [ROE] (2018) Analysis & Trends

From FY2009 onward, Sanofi has reported Return on Equity [ROE] for 16 years.

  • Return on Equity [ROE] shows a five-year change of +2.80 percentage points (FY2019 to FY2024).
  • Annual Return on Equity [ROE] has moved between 7.27% (FY2023) and 19.56% (FY2020) over five years.
  • Per Business Quant data, Return on Equity [ROE] in earlier years was 7.27% in FY2023 (-4.08 pp), 11.35% in FY2022 (+1.79 pp), 9.56% in FY2021 (-9.99 pp) and 19.56% in FY2020 (+14.90 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 19.33%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.63%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 21.60%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 72.13%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -31.17%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 4.66%
10 Sanofi 59.05 Bn 29.25 Bn 33.35 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2018 6.38%
API Access

Sanofi Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SNY&period=max&api_key=YOUR_API_KEY